Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Monday, March 20, 2023.
Celldex Therapeutics, Inc. (NASDAQ:CLDX)
Crossroads (-60) - CLDX is struggling to move into a solid trend. Beware of choppy markets and consider a sidelines position until a stronger trend is identified.
Is it time to buy, sell, or avoid CLDX?
MarketClub looks at technical strength and momentum to determine if the timing is right for CLDX.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for CLDX
The long-term trend has been UP since Aug 4th, 2022 at 33.35
The intermediate-term trend has been DOWN since Mar 20th, 2023 at 40.31
The short-term trend has been DOWN since Mar 9th, 2023 at 44.80
Smart Scan Analysis for CLDX
Based on our trend formula, CLDX is rated as a -60 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 40.50 | 41.80 | 39.57 | 41.61 | -0.23 |
| Prev. Close | Volume | Bid | Ask | Time |
| 41.84 | 599889 | 2023-03-20 15:59:45 |
| Year High | 3.08 | Year High Date | 2018-01-04 |
| Year Low | 0.282 | Year Low Date | 2018-11-27 |
| 52wk High | 48.4 | 52wk High Date | 2023-01-18 |
| 52wk Low | 19.85 | 52wk Low Date | 2022-06-13 |
| Year End Close | 6.71 | Average Volume | 531,098 |
| Shares Outstanding | 47,100 | Short Interest | 5,704,808 |
| % Institutional | 63.2 | Market Cap | 34M |
| Assets | 352,735,000M | Liabilities | 26,531,000M |
| Beta | 2.87 | Volatility | 75.78 |